Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A military helmet on a conference table with cybersecurity equipment in a dimly lit room.

Jul 28, 2026

US Army Europe and Africa advances AI cyber defence dialogue

The recent summit hosted by US Army Europe and Africa underscores the pivotal role of AI in enhancing military cybersecurity.Gathering over 800 cyber specialists, military leaders, and industry experts from 23 nations, the three-day event from July 21 to 23 focused on AI-driven cybersecurity, critical infrastructure protection, and the future of military cyber operations. Participants explored how current technologies can bolster operational readiness against evolving digital threats, emphasizin
A close-up of a bandaged diabetic foot ulcer on an examination table in a clinical setting.

Jul 28, 2026

AI-powered device to help treat diabetes patients unveiled by medtech firm

A new AI-driven device from Israeli startup TriO aims to significantly mitigate the risk of limb amputations due to diabetic foot ulcers, a severe complication of diabetes.Diabetic foot ulcers are a major concern for individuals with diabetes, often resulting from nerve damage, poor circulation, and elevated blood sugar levels. These ulcers not only pose a high risk of infection but also lead to costly and life-altering complications, including amputations.TriO's innovative device, called Fitt,
Silhouette of a microphone and a person representing leadership in biotechnology

Jul 28, 2026

Legend Biotech and Sarepta CEOs Depart as Patrick Vallance Named UK AI Task Force Chair

The biotechnology sector is experiencing notable leadership changes, with the CEOs of Legend Biotech and Sarepta Therapeutics stepping down, while Patrick Vallance has been appointed to chair the UK's new AI task force.Both Legend Biotech and Sarepta Therapeutics have announced the departures of their chief executives, although they have yet to name successors. This shift in leadership reflects broader transformations within the biotechnology industry, which is currently navigating a rapidly evo
Flat illustration of a tissue sample and research paper in a minimalist style.

Jul 28, 2026

Business Weekly Awards 2026: 44 shortlisted companies revealed for Cambridge Tech and Life Sciences showcase

The Business Weekly Awards 2026 has unveiled its shortlist, highlighting 44 innovative companies in the Cambridge tech and life sciences sectors, showcasing the region's robust ecosystem.The shortlist underscores the dynamic nature of the Cambridge Cluster, particularly its life sciences and technology companies. Many of these contenders have emerged from academic settings, reflecting the area's strong emphasis on research and innovation. Among the notable technology firms are 1956 Individuals,
A minimalist illustration of gears representing collaboration in AI.

Jul 28, 2026

Initech builds AI alliance with AIworks and Hypernology to target enterprise AX

Initech has partnered with AIworks and Hypernology to form an alliance focused on integrating various AI technologies into enterprise applications.On July 28, Initech, AIworks, and Hypernology announced a collaborative agreement to create an "AI alliance" that merges their strengths in industrial artificial intelligence, generative AI, and financial information technology. This partnership aims to identify new business opportunities across sectors such as manufacturing, finance, and public servi
A blood sample in a vial on a lab bench with a syringe.

Jul 28, 2026

Blood Testing Market to Surpass US$ 249.7 Billion by 2035, Fueled

The global blood testing market is projected to exceed $249.7 billion by 2035, driven by advancements in technology and an increasing burden of chronic diseases.The blood testing sector is experiencing significant growth, largely due to healthcare providers' reliance on blood diagnostics for disease detection and monitoring. As a crucial tool for evaluating health, blood tests facilitate early diagnosis and timely medical interventions, enhancing patient outcomes. The market, valued at approxima
An upward trend arrow representing rising healthcare stocks

Jul 28, 2026

Healthcare stocks climb as Gilead, Regeneron and Bristol Myers lead gains across pharma sector

Healthcare stocks experienced a notable uptick, driven by significant gains from key players like Gilead Sciences, Regeneron Pharmaceuticals, and Bristol Myers Squibb.During a recent trading session, the healthcare sector saw a positive shift, with Gilead Sciences rising by 2.88%, closely followed by Regeneron Pharmaceuticals at 2.89%. Bristol Myers Squibb also contributed to the rally with a 2.11% increase. Other major companies, including Zoetis, Johnson & Johnson, Pfizer, Merck, and AbbVie, a
A flat illustration of a proxy drug molecule interacting with a target protein in a laboratory setting.

Jul 28, 2026

Insights from SLAS Europe 2026 - SelectScience interview

At the Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), researchers are pioneering the integration of academic research and industrial applications in drug discovery. Their focus is on developing proximity-inducing drugs, which differ from traditional small molecules by modulating protein interactions rather than merely inhibiting protein functions.Proximity-inducing drugs, or proxy drugs, operate by binding to a target protein and recruiting another protein via mechanism
A pill bottle and scattered pills on a pharmacy shelf in dim light.

Jul 28, 2026

AstraZeneca boss urges western drugmakers to move at ‘Chinese speed’

AstraZeneca's CEO, Pascal Soriot, emphasizes the need for Western pharmaceutical companies to adopt a faster pace of innovation, akin to that seen in China's rapidly advancing industry. He warns that without this shift, they risk falling behind more agile competitors, similar to the challenges faced by the Western automotive sector.Soriot's comments reflect a growing concern within the industry about the competitive landscape, particularly as China's pharmaceutical sector continues to innovate a
A minimalist representation of a single cell and gene strands in a dark palette.

Jul 28, 2026

Novogene Europe Adds Single-Cell Sequencing at Cambridge Omics Centre

Novogene Europe has enhanced its single-cell RNA sequencing capabilities at the Cambridge Omics Centre, providing advanced sequencing services to researchers in the UK.This development leverages Novogene's established expertise in single-cell technologies, integrating specialized project support, sequencing infrastructure, and bioinformatics analysis. The aim is to facilitate deeper biological insights from complex samples, responding to the increasing demand for accessible single-cell transcrip
Handheld diagnostic device for COPD testing on a wooden table in a clinical setting.

Jul 28, 2026

Tidalsense raises $19M for AI-powered COPD diagnostic platform

Tidalsense Ltd. has successfully secured $19 million in funding to advance its AI-driven diagnostic platform aimed at identifying chronic obstructive pulmonary disease (COPD).The company’s N-Tidal Diagnose platform offers a rapid diagnostic test that can detect COPD within five minutes. This innovative approach involves a simple procedure where users breathe normally into a handheld device for 75 seconds, capturing a carbon dioxide breath waveform. The data is then analyzed using artificial inte
A vial of medication on a laboratory shelf in a dimly lit setting.

Jul 27, 2026

AstraZeneca boss urges western drugmakers to move at ‘Chinese speed’

AstraZeneca's CEO, Pascal Soriot, emphasizes the need for Western pharmaceutical companies to adopt a faster pace of innovation, akin to that of China's rapidly advancing drug industry. He warns that without this shift, they risk losing competitiveness, similar to the challenges faced by the Western automotive sector.Soriot highlighted AstraZeneca's commitment to achieving ambitious growth targets, aiming for $80 billion in annual sales by 2030. The company reported a 6% revenue increase in the